Jamie is a physician associate (PA) in haematology, and is currently the lead physician associate at University College London Hospitals (UCLH). He graduated in 2017 and has worked in haematology since then. He has completed clinical rotations in haemato-oncology, caring for patients undergoing chemotherapy and other anti-cancer treatments, and haemoglobinopathies, caring predominantly for patients with sickle cell disease. He has a clinical interest in myeloid malignancies (acute leukaemias, myelodysplastic neoplasms and myeloproliferative neoplasms), as well as an interest in education. In his spare time Jamie is a budding cyclist, and enjoys learning foreign languages.
Dr Okoli is a Consultant at Hammersmith Hospital, Imperial College Healthcare NHS Trust, with a specialist interest in red cell disorders. His main area of practice are in the fields of sickle cell disease and rare anaemias. He is the sub-specialty lead for the North West London Local Clinical Research Network, and is principal investigator for several clinical studies in red cell disorders. He is also the adult stem cell transplant lead for sickle cell disease at Imperial College NHS Trust.
Dr Okoli’s interest in red cell haematology began as a pharmacist at King’s College Hospital, London. In this role, he completed a lab-based project exploring the treatment of patients with sickle cell disease.
After obtaining his undergraduate medical qualification from Glasgow University in 2005, he went on to complete his haematology training in South West London, based mainly at Guy’s & St Thomas’ Hospitals. He subsequently undertook a one-year Research Fellowship in rare anaemias at the Weatherall Institute, Oxford, before embarking on his PhD investigating treatments for G6PD deficiency. Following this Dr Okoli undertook several posts as a red cell haematology consultant at large teaching hospitals in South London.
He is an Honorary Senior Clinical Lecturer at Imperial College. In this role, Dr Okoli is actively involved in academic research in sickle cell disease and teaches undergraduates at the college.
Dr Rachel Kesse-Adu is a consultant haematologist who graduated in medicine from Imperial College School of Medicine in 2002, she completed her specialist training in haematology at Kings College Hospital in London in 2012.
She was appointed to a Consultant Haematologist position at Guy’s and St Thomas Hospital where she continues to work, she was appointed to the clinical lead position for the department in March 2022.
Dr Kesse-Adu has specialist interest in Sickle cell disease and post graduate medical education. Her particular areas of interest in sickle are cardiorespiratory, chronic pain and urological complications of the condition, she runs joint specialist clinics in these areas.
She is actively involved in clinical research in sickle cell disease and is chief and principal investigator on a number of ongoing trials. She is additionally medical advisor to the UK Sickle Cell Society and Treasurer for the UK forum on haemoglobin disorders. She is the Training program director for the London South Central rotation, and is heavily involved in teaching and training of haematology specialist trainees.
I’m a Consultant in Renal Transplant & Dialysis Access Surgeon, Lead for Robotic renal failure Surgery, Access for Dialysis, Research and Education at Bartshealth NHS Trust.
I completed training in abdominal organ transplatation in Addenbrooke’s Hospital Cambridge and conducted research in cellular Biology at University of Cambridge. Currently, I am a primary investigator for NIHR funded research trials on renal transplantation, Access for dialysis and Co-Chair for Robotic research programme in Bartshealth NHS Trust. My research work is presented in many international conferences, published in peer-reviewed journals and was involved in the creation of world’s first risk score to predict outcome following intestinal transplantation.
I performed the first renal transplantation in Live TV /any form of multimedia and believe that improving patient engagement is essential to enhance the care offered to our patients with long-term illnesses including renal & pancreas transplantation. I am passionate about improving knowledge about donation from live and deceased donors, particulary in BAME communities and lead and actively involved with many local and national initiatives. I stirve to offer a safe and excellent care to our patients and shall continue our efforts to increase the rate of organ donation from ethnic minorities.
I am the lead for Education and deliver both undergraduate and post-graduate education in renal failure surgery at Bartshealth NHS trust and improved the oppurtunitues offered to school students from East London who are willing to puruse a career in health care. The structutred work experience offered to students in the recent and it was recognised at the Bartshealth Community Awards 2018.
I am a Haematology Clinical Fellow and have been fortunate to have worked at tertiary Haematology centres at Guys and St.Thomas’s and UCLH. I have experience working in both non-malignant and malignant haematology and have a special interest in haemoglobinopathies. I would like to specialise in this area, particularly looking at health inequalities in patients from ethnic minorities and haematologists can address these issues to improve patient care.
Dr Delordson Moinina Kallon, PhD. is the director of the Clinical Transplantation Pathology Service in the largest hospital group in the UK, the Barts Health NHS Trust. With over 26 years’ experience in molecular diagnostics, Delordson leads a team of scientists providing complex diagnostic services to seven hospitals across the East and Southeast of London, including to kidney patients at the Royal London Hospital, heart and lung disease children at the world-famous Great Ormond Street Hospital for Children (GOSH) and blood cancer patients at St. Barts Hospital.
In additional to his clinical duties, Delordson is a Senior Lecturer at Queen Mary University London, where he is the co-module lead for the Cancer MSc Molecular Diagnostics and Therapeutics course, helping to oversee the training of doctors and scientists in blood cancer diagnosis and treatment.
Dr Kallon obtained his PhD in Cancer Studies from King’s College Medical School and was admitted as a Fellow into the UK Royal College of Pathologists in 2019. He sits on a number of UK national advisory panels including the Cardiothoracic Transplant Advisory Group (CTAG). He is the author of the leading text on molecular diagnostic testing in transplantation – http://www.histocompatibilityandimmunogenetics.com.
